上海市医疗废物控制系统建设设想

根据上海的实际情况，借鉴国内外先进的医疗废物管理、处置经验，从控制的角度全面阐述了上海市医疗废物控制系统的目标、集中处置系统以及配套系统等各个方面建设的具体设想。     

Test of membrane bioreactor for waste water treatment in a petrochemical complex

Membrane bioreactor (MBR) used in water and waste water treatment is a developing technique for water pollution control and water reuse. This paper describes a membrane-bioreactor for treatment of waste water in a petrochemical complex. The experimental MBR was a lab scale one composed of an activated sludge bioreactor unit and an ultrafiltration membrane unit. The relationship of COD removal with MLSS and HRT in this MBR was studied. The effects of crossflow velocity, backwash interval and volume of flush liquid on the flux were discussed. The results showed that average removal of COD, oil, SS and turbidity in petrochemical waste water by the MBR was 91%, 86%, 92% and 99% respectively. The average removal of NH₃-N and total phosphorous was 85% and 82%. A coefficient of COD removal, k, was 0.017-0.080 L/(mg.d). The membrane flux maintained higher than 60 L/hm2 bar for 34 days without chemical cleaning when the velocity of crossflow was 3.5-3.9 m/s and the backwash interval was 30 minutes and backwash duration at 20 seconds. The results indicated that it is feasible for MBR technology to be used in petrochemical waste water treatment. The treated water could be considered as a source used to make up water for industrial cooling system or to be reused for other purposes.     

用水基表面活性剂乳液回收废白土中蜡的界面张力研究

通过测定液体与废白土粉末之间的接触角及液体与蜡之间的液液界面张力，对水基表面活性剂乳液的溶剂及配方进行了优选，得到最佳的水基面活性剂乳液的组成为：质量分数０．２％的十二烷基苯磺酸钠＋体积分数为２．５％的乙醇＋体积分数为２５％的混合烃（正己烷＋苯，等体积）＋体积分数为７２．５％的水。实验证明，用该水基表面活性剂乳液处理废白土，蜡的回收率可达８０％，同时不破坏白土的颗粒结构。     

Second-trimester cancer antigen 125 and Down's syndrome

This study explores if assay of cancer antigen 125 (CA 125) in maternal serum might aid the detection of Down's syndrome in the second trimester of pregnancy. CA 125 levels were determined retrospectively in stored maternal serum samples from ten Down's syndrome pregnancies and 78 controls matched for gestational and maternal age. In addition, second-trimester amniotic fluid samples from nine Down's syndrome and 109 unaffected pregnancies were analysed for CA 125. Maternal serum CA 125 values for Down's syndrome pregnancies were lower, with the median being 0.72 multiples of the unaffected population median. The medians for affected and unaffected pregnancies did not differ significantly and there was a considerable overlap in the range of values of cases and controls. The distribution of amniotic fluid CA 125 levels for Down's syndrome pregnancies resembled that for controls. From our present results, we could not find an association between Down's syndrome and second-trimester maternal serum or amniotic fluid CA 125 levels.     

S-100 protein and neuron-specific enolase in amniotic fluid as markers of abdominal wall and neural tube defects in the fetus

The aim of this study was to determine whether there is increased leakage of neuron-specific enolase (NSE) and S-100 protein into amniotic fluid in pregnancies with neural tube defects, since both these proteins are produced by neural tissue, and to compare the value of these substances for detecting such defects with that of the more conventional techniques of alpha-fetoprotein (AFP) and acetylcholinesterase (AChE) gel electrophoresis. Amniotic samples from 25 mid-pregnancies (15–17 weeks' gestation) with neural tube defects (14 with open spina bifida and 11 with anencephaly) and from seven mid-pregnancies with abdominal wall defects were compared with a control material consisting of 80 amniotic fluid samples from 80 consecutive mid-pregnancy amniocenteses, with normal karyotypes and AFP concentrations. All of the above cases of abnormalities were primarily detected through increased AFP levels in the amniotic fluid. Amniotic fluid samples from 13 pregnancies with fetuses with autosomal chromosomal abnormalities and seven amniotic fluid samples contaminated with blood were also included in the investigation. It is concluded from the results that the conventional AFP assay combined with AChE gel electrophoresis is the best method for screening amniotic fluid for neural tube defects and defects of the abdominal wall. Neither NSE nor S-100 assay alone proved to be superior for the detection of these cases in mid-trimester amniotic fluid. The S-100 assay, however, could give additional information in cases where AChE gel electrophoresis is not decisive; for example, in samples contaminated with blood.     

Evaluation of inorganic pyrophosphate in amniotic fluid as a mode of prenatal diagnosis of osteogenesis imperfecta

Using a modified procedure by Solomons and Styner (1969), an evaluation of inorganic pyrophosphate (PPi) was performed on the amniotic fluid of two fetuses at risk for osteogenesis imperfecta (OI) at 14½ weeks gestation. The parents of both cases had a previous child with OI, Type II. The normal control group at 14–16 weeks gestation had PPi values ranging from 22.0–59.2 ug/100 ml, with a mean of 38.6±9.51 ug/100 ml. In each at-risk fetus, the amniotic fluid PPi value was within normal range. The first baby was born phenotypically normal at term. Intrauterine radiographic and fetal sonograms were done on the second fetus at approximately 19 weeks gestation. Both showed evidence of OI, Type II. The pregnancy was terminated at 21 weeks. Radiologic studies of the aborted fetus were consistent with OI, Type II. Our results indicate that the evaluation of PPi levels in amniotic fluid is not the method of choice for prenatal diagnosis of IO.     

天然矿石毒重石吸附硫酸盐废水的试验研究

利用天然矿石毒重石对硫酸盐废水进行吸附处理，在废水的pH=9，停留时间为80min左右时，该吸附剂具有较好的吸附效果。且该离子交换吸附法具有成本低、操作简单、无二次污染的优点。     

炼油污水处理场技术改造

对广州石化炼油新污水处理场现状进行了分析 ,针对存在问题 ,通过更换原有设备 ,增加新设备对其进行了技术改造 ,大大地提高了外排污水合格率     

生物膜填料塔处理浓度有机废气的工业应用试验研究

工业应用试验研究表明，生物膜填料塔处理工业有机废气是可行的，当运行条件控制适当时，净化效率可保持在90％以上，能够实现达标排放，这一成果填补了我国环保工业技术领域的空白，工程技术上接近现阶段国外的技术研究水平。     

企业开展污水回用工作存在的主要问题及对策

发挥政府职能,转变用水观念,拓展筹资方式,开发回用水市场,降低成本等是企业解决污水回用问题的有效对策和措施.文章对泰皇岛港务集团公司污水回用工作的成功实践进行了分析,该实例表明企业完全可以开展污水回用工作,工程社会、经济、环境效益明显,实际运行经验可供其他企业借鉴.